Test Price
2,800 AED✅ Home Collection Available
DNAJC6 Gene (PARK19) Juvenile-Onset Parkinson Disease Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DNAJC6 (PARK19) لمرض باركنسون مبكر الظهور في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
📋 Executive Summary ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM‑11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation by DHA‑licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- دقة تشخيصية 99.9% عبر مختبر معتمد دولياً – خدمة سحب منزلي متميزة ونقل مبرد وفق معايير الجودة.
Overview
The DNAJC6 Gene (PARK19) Juvenile‑Onset Parkinson Disease Genetic Test uses Next‑Generation Sequencing to detect pathogenic variants in the PARK19 locus, confirming a hereditary form of parkinsonism that typically begins before age 21. This test is essential for accurate diagnosis, family risk assessment, and guiding long‑term neurological care. يكشف تحليل الجين DNAJC6 عن طفرات وراثية تسبب مرض باركنسون المبكر، ويساعد في التشخيص الدقيق وتخطيط الرعاية العصبية.
| Feature | Our Test (DNAJC6 NGS) | Closest Alternative (Sanger / Panel) |
|---|---|---|
| Precision | >99.9% sensitivity, full gene coverage | Limited to known hotspots |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing / targeted panel |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Sample Type | Blood, Extracted DNA, or One‑drop FTA Card | Blood only |
Physician Insight & Safety Protocol
“As a DHA‑licensed neurologist, I emphasize that this genetic test confirms the molecular diagnosis but must always be correlated with clinical findings and a detailed family history. A positive result does not inevitably predict symptom onset, and a negative result does not exclude other parkinsonian syndromes. Please discuss all results with your treating neurologist before making any clinical decisions.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria: Inability to provide a blood/DNA sample, lack of informed consent, individuals under legal guardianship without proper authorization.
ER Red Flags: Acute psychiatric symptoms, rapid neurological deterioration, or any acute medical crisis – seek emergency care immediately.
Pre‑Test Information & Special Requirements
- A detailed clinical history and a genetic counselling session to draw a pedigree chart of affected family members are mandatory before sample collection.
- Avoidance of certain supplements/drugs may be advised by the genetic counsellor; however, the standard NGS workflow does not require routine dietary restrictions.
- Home collection is available for whole blood or FTA card; cold‑chain logistics ensure sample integrity.
Patient FAQ & Clinical Guidance
1. What is the DNAJC6 gene test and who should consider it?
The DNAJC6 NGS test analyzes the entire PARK19 gene to detect variants causing juvenile‑onset Parkinson disease, and it is recommended for individuals with early‑onset parkinsonian symptoms, a positive family history, or unexplained movement disorders.
تحليل الجين DNAJC6 يفحص الجين بالكامل للكشف عن الطفرات المسببة لمرض باركنسون المبكر، ويُوصى به للأشخاص الذين تظهر عليهم أعراض مبكرة أو لديهم تاريخ عائلي للمرض.
2. How is the performed and how long do results take?
A simple blood draw, a drop of blood on an FTA card, or extracted DNA is collected, and results are typically available within 3 to 4 weeks using high‑throughput NGS technology.
يتم سحب عينة دم بسيطة أو وضع قطرة دم على بطاقة FTA، وتظهر النتائج عادة خلال 3 إلى 4 أسابيع باستخدام تقنية التسلسل الجيني المتقدم.
3. What do the results mean for my health and my family?
A positive result confirms a genetic susceptibility to juvenile‑onset Parkinson disease and enables early intervention and family screening, while a negative result reduces but does not eliminate the possibility of another genetic or idiopathic form.
النتيجة الإيجابية تؤكد القابلية الوراثية لمرض باركنسون المبكر وتسمح بالتدخل المبكر وفحص أفراد الأسرة، أما النتيجة السلبية فتقلل الاحتمال ولكنها لا تنفي وجود أسباب وراثية أخرى.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians